Changes in serum lipids and antioxidant status in west Algerian patients with essential hypertension treated with acebutolol compared to healthy subjects

Medical Science Monitor

Volumn 9, Issue 8, 2003, Pages

  Krouf, Djamil ^a   Bouchenak, Malika ^a   Mohammedi, Bachir ^b   Cherrad, Allaoua ^c   Belleville, Jacques ^d   Prost, Josiane ^d  

^a UNIVERSITY OF ORAN   (Algeria)

^b Clinique de Cardiologie   (Algeria)

^c Laboratoire de Biochimie Clinique   (Algeria)

^d UNIVERSITÉ DE BOURGOGNE   (France)

Author keywords

1 blockers; Antioxidant enzymes; Essential hypertension; Fatty acids; Lipids

Indexed keywords

ACEBUTOLOL; ANTIOXIDANT; APOLIPOPROTEIN A1; CATALASE; FATTY ACID; GLUTATHIONE REDUCTASE; LIPID; SUPEROXIDE DISMUTASE; TRIACYLGLYCEROL;

ADULT; ARTICLE; BLOOD PRESSURE MEASUREMENT; CLINICAL ARTICLE; CONTROLLED STUDY; DEVELOPED COUNTRY; DEVELOPING COUNTRY; DOSE RESPONSE; ECHOCARDIOGRAPHY; ENZYME ACTIVITY; ERYTHROCYTE; ESSENTIAL HYPERTENSION; HUMAN; LABORATORY TEST; LIPID COMPOSITION; LIPID PEROXIDATION; MALE; PHYSICAL EXAMINATION;

ACEBUTOLOL; ADRENERGIC BETA-ANTAGONISTS; ADULT; ALGERIA; ANTIHYPERTENSIVE AGENTS; ANTIOXIDANTS; APOLIPOPROTEIN B-100; APOLIPOPROTEINS A; APOLIPOPROTEINS B; BLOOD PRESSURE; CELL MEMBRANE; ERYTHROCYTES; HUMANS; HYPERTENSION; LIPIDS; MALE; MIDDLE AGED;

EID: 0141707025     PISSN: 12341010     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (37)

1. Das UN: Nutritional factors in the pathobiology of human essential hypertension. Nutrition, 2001; 17: 337-346
2. Loverro G, Greco P, Capuano F et al: Lipoperoxidation and antioxidant enzymes activity in pregnancy complicated with hypertension. Eur J Obstet Gynecol Reprod Biol, 1996; 70: 123-127
3. Halliwell B, Gutteridge JM: The antioxidants of human extracellular fluids. Arch Biochem Biophys, 1990; 280: 1-8
4. Russo C, Olivieri O, Girelli D et al: Anti-oxidant status and lipid peroxidation in patients with essential hypertension. J Hypertens, 1998; 16: 1267-1271
5. Kumar CA, Das UN: Lipid peroxides, anti-oxidants and nitric oxide in patients with pre-eclampsia and essential hypertension. Med Sci Monit, 2000; 6: 901-907
6. Michiels C, Raes M, Toussaint O et al: Importance of Se-glutathion peroxidase, catalase and Cu/Zn SOD for cell survival against oxidative stress. Free Radic Biol Med, 1994; 17: 235-248
7. Fridovich I, Freeman B: Antioxidant defenses in the lung. Annu Rev Physiol, 1986; 48: 693-702
8. Marklund SL: Extracellular superoxide dismutase in human tissues and human cell lines. J Clin Invest, 1984; 74: 1398-1403
9. Crapo JD, Oury T, Rabouille C et al: Copper-zinc superoxide dismutase in primarily a cytosolic protein in human cells. Proc Natl Acad Sci USA, 1992; 89: 10405-10409
10. Engstrom PC, Easterling L, Baber RR et al: Mechanisms of extracellular hydrogen peroxide clearance by alveolar type II pneumocytes. J Appl Physiol, 1990; 69: 2078-2084
11. Kinnula VL, Pietarinen, P, Aalto K et al: Mitochondrial superoxide dismutase induction does not protect epithelial cells during oxidant exposure in vitro. Am J Physiol, 1995; 268: 71-77
12. Heffner JE, Repine JE: Pulmonary strategies of antioxidant defense. Am Rev Respir Dis, 1989; 140: 531-554
13. Esworthy RS, Ho YS, Chu FF: The GPx1 gene encodes mitochondrial glutathione peroxidase in the mouse liver. Arch Biochem Biophys, 1997; 340: 59-63
14. Cantin AM, North SL, Hubbard RC et al: Normal alveolar epithelial lining fluid contains high levels of glutathione. J Appl Physiol, 1987; 63: 152-7
15. Sproat TT, Lopez, LM: Around the beta-blockers, one more time. DICP, 1991; 25: 962-971
16. Tse WY, Maxwell SR, Thomason H et al: Antioxidant status in normotensive subjects and unnormotensive subjects: hypertension and its relationship to endothelial damage. J Hum Hypertens, 1994; 8: 843-849
17. Zicha J, Kunes J, Devynck MA: Abnormalities of membrane function and lipid metabolism in hypertension: a review. Am J Hypertens, 1999; 12: 315-331
18. Srinivas K, Bhaskar MV, Aruna Kumari R et al: Antioxidants, lipid peroxidation and lipoproteins in primary hypertension. J Indian Heart, 2000; 52(3): 285-8
19. Guidelines Subcommittee. 1999 World Health Organization - International Society of Hypertension. Guidelines for the Management of Hypertension. J hypertension 1999; 17: 151-83
20. McGown EL, Rusnak MG, Lewis CM et al: Tissue ascorbic acid analysis using ferrozine compared with the dinitrophenylhydrazine method. Anal Biochem. 1982; 119: 55-61
21. Burton GW, Ingold KU, Thompson KE: An improved procedure for the isolation of ghost membranes from human red blood cells. Lipids, 1981; 16: 946-951
22. Folch J, Lees M, Sloane-Stanley GH: A simple method for the isolation and purification of total lipids from animal tissues. J Biol Chem, 1957; 226: 497-509
23. Slover HT, Lanza E: Quantitative analysis of food fatty acids by capillary gas chromatography. J Am Oil Chem Soc, 1979; 56: 933-943
24. Blache D, Prost M: Free radical attack: biological test for human resistance capability. Ponnamperuma C, Gehrke C. W. eds. A Lunar-Based Chemical Analysis Laboratory, 1992: 82-98 Deepak A. Hampton, VA
25. Aebi H: Catalase. In Methods of enzymatic analysis. 2nd ed. Edited by H. U Bergmeyer. Verlag Chemie GmbH, Weinheim, 1974; 2: 673-684
26. Goldberg D, Spooner R: Glutathion reductase. In Methods of enzymatic analysis. Bergmeyer, H, 3rd ed, 1992; 3: 258-265
27. Elsmer E, Youngman R, Obwald W: Superoxide dismutase. In: Methods of enzymatic analysis. Bergmeyer H, 3rd ed, 1983; 3: 293-302
28. Day JL, Metcalfe J, Simpson CN: Adrenergic mechanisms in normotensive subjects of serum lipid concentrations. Br Med J (Clin Res Ed), 1982; 284: 1145-1148
29. Jansen H, Baggen RG: Effects of doxazosin and propranolol administration on lipoprotein lipases in cholesterol-fed rats. J Cardiovasc Pharmacol, 1987; 10: S16-20
30. Superko HR, Haskell WL, Krauss RM: Association of lipoprotein subclass distribution with use of selective and non-selective beta-blocker medications in patients with coronary heart disease. Atherosclerosis, 1993; 101: 1-8
31. Lehtonen A, Marniemi J, Niittymaki K: The effect of acebutolol on serum apoproteins and HDL cholesterol subfractions. Res Commun Chem Pathol Pharmacol, 1985; 47: 427-435
32. Netea RT, Netea MG, Bredie SJ et al: Lipoprotein (a) concentrations in patients with familial combined hyperlipidemia and hypertension. Neth J Med, 1999; 55: 39-45
33. Garcia CE, Kilcoyne CM, Cardillo C et al: Effect of copper-zinc superoxide dismutase on endothelium-dependent vasodilation in patients with essential hypertension. Hypertension, 1995; 26: 863-868
34. McIntyre M, Bohr DF, Dominiczak AF: Endothelial function in hypertension: the role of superoxide anion. Hypertension. 1999; 34: 539-545
35. Duffy SJ, Gokce N, Holbrook M et al: Treatment of hypertension with ascorbic acid. Lancet, 1999; 354: 2048-2049
36. Solzbach U, Hornig B, Jeserich M et al: Ascorbate improves endothelial dysfunction of epicardial coronary arteries in hypertensive subjects. Circulation, 1997; 96: 1513-1519
37. Ness AR, Chee D, Elliott P: Ascorbate and blood pressure: an overview. J Hum Hypertens, 1997; 11: 343-350